Header Logo

Connection

Elizea Horne to Anti-HIV Agents

Back to Details
This is a "connection" page, showing publications Elizea Horne has written about Anti-HIV Agents.
Elizea Horne
Connection Strength
0,128
Anti-HIV Agents
  1. Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother-infant pairs (MTN-043): a phase 3B, open-label, randomised trial. Lancet HIV. 2025 Mar; 12(3):e180-e190.
    View in: PubMed
    Score: 0,128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.